Your browser doesn't support javascript.
loading
Corrigendum to "Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells" [Int. Immunopharmacol. 101 (2021) 108288].
Fathi, Mehrdad; Bahmanpour, Simin; Barshidi, Asal; Rasouli, Hossein; Kiani, Fariba Karoon; Khesht, Armin Mahmoud Salehi; Izadi, Sepideh; Rashidi, Bentolhoda; Kermanpour, Shiva; Mokhtarian, Roya; Karpisheh, Vahid; Hassannia, Hadi; Mohammadi, Hamed; Jalili, Ali; Jadidi-Niaragh, Farhad.
Afiliação
  • Fathi M; Student Research Committee, Kurdistan University of Medical Sciences, Sanandaj, Iran; Cancer and Immunology Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran; Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
  • Bahmanpour S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Barshidi A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Rasouli H; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kiani FK; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Khesht AMS; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Izadi S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Rashidi B; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Kermanpour S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Mokhtarian R; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Karpisheh V; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Hassannia H; Immunogenetic Research Center, Faculty of Medicine and Amol Faculty of Paramedical Sciences, Mazandaran University of Medical Sciences, Sari, Iran.
  • Mohammadi H; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
  • Jalili A; Cancer and Immunology Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran; Department of Immunology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran. Electronic address: Ali130@gmail.com.
  • Jadidi-Niaragh F; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Department of Immunology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: jadidif@tbzmed.ac.ir.
Int Immunopharmacol ; 142(Pt A): 113118, 2024 Dec 05.
Article em En | MEDLINE | ID: mdl-39271379
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Irã